Genetic deletion of MMP10 reduces peritoneal fibrosis, inflammation, VEGF-A expression, number of CD31-positive vessels, and elevated peritoneal solute transport rates in a mouse model exposed to chlorhexidine gluconate. The gene discussed is VEGFA; the disease is Peritoneal Fibrosis.